glucose, (beta-d)-isomer has been researched along with Diabetic Neuropathies in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 6 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsalam, RM; El-Safty, H; El-Sahar, AE; Ismail, A; Saad, MA | 1 |
| Gao, Y; Li, X; Xu, L; Yang, X; Zhu, Y | 1 |
| Abdelkader, NF; Elbaset, MA; Ibrahim, SM; Moustafa, PE | 1 |
| Bheereddy, P; Kalvala, AK; Kumar, A; Sherkhane, B; Yerra, VG | 1 |
| Bian, F; Chen, L; Hao, X; Lei, P; Lu, W; Ma, W; Wang, Q; Zhang, L; Zhang, Y; Zhao, Y; Zheng, T | 1 |
| Ang, L; Dillon, B; Fang, F; Kidwell, KM; Leone, V; Mizokami-Stout, K; Pop-Busui, R; Reiss, J | 1 |
| Cui, R; Ni, GL; Shao, AM; Wu, ZM | 1 |
| Bujalska-Zadrożny, M; Czerwińska, ME; Gąsińska, E; Kiss, AK; Krawczyk, P; Leśniak, A; Naruszewicz, M | 1 |
| Hayashizaki, Y; Takakura, S; Takasu, T; Toyoshi, T | 1 |
| Hu, B; Li, DQ; Wang, CF; Xue, HY | 1 |
| Kase, Y; Kobayashi, H; Lee, KK; Omiya, Y; Yuzurihara, M | 1 |
| Duan, JH; Han, WJ; Hu, SJ; Luo, C; Miao, B; Sun, W; Wang, WT; Wang, XC; Ye, X | 1 |
| Chen, W; Chen, Y; Huang, X; Li, L; Li, Z; Zhang, L | 1 |
| Arakawa, K; Fujita, T; Ishihara, T; Matsumoto, Y; Nawano, M; Oku, A; Saito, A; Ueta, K | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Diabetic Neuropathies
| Article | Year |
|---|---|
Dapagliflozin and measures of cardiovascular autonomic function in patients with type 2 diabetes (T2D).
Topics: Aged; Benzhydryl Compounds; Blood Glucose; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Prospective Studies; Treatment Outcome | 2021 |
13 other study(ies) available for glucose, (beta-d)-isomer and Diabetic Neuropathies
| Article | Year |
|---|---|
Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Glycogen Synthase Kinase 3 beta; Memory Disorders; Neuroprotective Agents; Rats; Signal Transduction; Wnt3 Protein | 2022 |
Paeoniflorin Upregulates Mitochondrial Thioredoxin of Schwann Cells to Improve Diabetic Peripheral Neuropathy Indicated by 4D Label-Free Quantitative Proteomics.
Topics: Animals; Diabetes Mellitus; Diabetic Neuropathies; Glucosides; Monoterpenes; Proteomics; Rats; Schwann Cells; Thioredoxins | 2022 |
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling.
Topics: AMP-Activated Protein Kinases; Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose; Glucosides; MicroRNAs; Rats; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2022 |
SIRT1 Activation by Polydatin Alleviates Oxidative Damage and Elevates Mitochondrial Biogenesis in Experimental Diabetic Neuropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Mice; Mitochondria; Organelle Biogenesis; Oxidative Stress; Sirtuin 1; Stilbenes; Streptozocin | 2021 |
Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; Glucosides; Hypoglycemic Agents; Inflammasomes; Insulin Resistance; Male; Neuralgia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pain Threshold; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Salidroside Ameliorates Diabetic Neuropathic Pain in Rats by Inhibiting Neuroinflammation.
Topics: Analgesics; Animals; Diabetic Neuropathies; Glucosides; HEK293 Cells; Humans; Interleukin-1beta; Nociception; Phenols; Rats; Rats, Zucker; Receptors, Purinergic P2X7; Sciatic Nerve; Spinal Cord; Tumor Necrosis Factor-alpha | 2017 |
Inhibitory effect of Ligustrum vulgare leaf extract on the development of neuropathic pain in a streptozotocin-induced rat model of diabetes.
Topics: Aldehydes; Animals; Chromatography, High Pressure Liquid; Cyclopentane Monoterpenes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Glycosides; Hyperalgesia; Iridoid Glucosides; Iridoids; Ligustrum; Male; Neuralgia; Phenols; Plant Extracts; Plant Leaves; Rats; Streptozocin | 2018 |
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Glucosides; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2016 |
Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats.
Topics: Administration, Oral; Animals; Behavior, Animal; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucosides; Glutathione Peroxidase; In Situ Nick-End Labeling; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Nerve Growth Factor; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2010 |
Antinociceptive effect of paeoniflorin via spinal α₂-adrenoceptor activation in diabetic mice.
Topics: Analgesics; Animals; Animals, Outbred Strains; Benzoates; Bridged-Ring Compounds; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Glucosides; Male; Mice; Monoterpenes; Nociception; Norepinephrine; Receptors, Adrenergic, alpha-2 | 2011 |
Gastrodin inhibits allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing excitability of nociceptive primary sensory neurons.
Topics: Animals; Benzyl Alcohols; Capsaicin; Diabetic Neuropathies; Glucosides; Hyperalgesia; Rats; Sensory Receptor Cells; Streptozocin | 2012 |
[Effects of naokang erhao decoction on cognitive ability and hippocampal apoptosis-related proteins in diabetic rats].
Topics: Abietanes; Acetophenones; Animals; Apoptosis; bcl-2-Associated X Protein; Benzoates; Bridged-Ring Compounds; CA1 Region, Hippocampal; Caspase 3; Cognition Disorders; Diabetic Neuropathies; Drug Combinations; Drugs, Chinese Herbal; Glucosides; Male; Maze Learning; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Rats | 2011 |
Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
Topics: Administration, Oral; Animals; Carbonates; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diet; Disease Models, Animal; Enzyme Inhibitors; Female; Glucose; Glucose Tolerance Test; Glucosides; Hyperglycemia; Insulin Resistance; Male; Membrane Glycoproteins; Monosaccharide Transport Proteins; Rats; Rats, Inbred Strains; Rats, Wistar; Sodium; Sodium-Glucose Transporter 1; Time Factors | 2005 |